Simulations Plus, Inc.
NASDAQ:SLPMedical - Healthcare Information Services
+$0.02 today
- Market cap
- $374.16M
- Beta
- 1.32
- P/E (TTM)
- -5.9
- EPS (TTM)
- -$3.12
Volume 0.00M
Average 0.35M
SLP Weighted Avg Shares
Average number of basic shares outstanding during the period, used to calculate basic EPS.
Simulations Plus, Inc.NASDAQ: SLP
Weighted Avg Shares · Q2 FY2026 · quarter ended Feb 2026
Weighted avg shares grows in line with its trailing trend
Q2 FY2026 weighted avg shares of 20.15M shares rose 0.3% year over year, in line with the +0.4% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at -0.2% a year.
Context
- Weighted avg shares increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from +0.3% toward the trailing-twelve-month pace of +0.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Weighted Avg Shares history
Shares · from the income statement
- Latest · FY2025
- 20.1M USD
- Year-over-year change
- +0.6%
- 4-year CAGR
- +0.1%
| Period | Period end | Weighted Avg Shares | YoY change |
|---|---|---|---|
| FY2025 | 2025-08-31 | 20.1M | +0.6% |
| FY2024 | 2024-08-31 | 19.99M | -0.4% |
| FY2023 | 2023-08-31 | 20.08M | -0.6% |
| FY2022 | 2022-08-31 | 20.2M | +0.8% |
| FY2021 | 2021-08-31 | 20.05M | — |
Weighted Avg Shares vs competitors
How SLP compares with its peers on the latest reported figures
- SLP's LTM Feb 2026 weighted avg shares of 20.14M shares is the 7th highest of the 11 companies compared; the peer median is 25.98M shares.
- Its year-over-year change of +0.4% is the 8th highest of 11, against a peer median of +2.1%.
- Over three fiscal years its annual growth of -0.2% compares with a peer median of +2.9%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | 104.66M | -9.4% | +1.8% | |
| LTM Mar 2026 | 100.38M | +2.9% | +30.1% | |
| LTM Mar 2026 | 99.9M | -2.5% | +6.4% | |
| LTM Mar 2026 | 68.62M | +3.6% | +1.8% | |
| LTM Mar 2026 | 29.75M | +10.2% | +4.1% | |
| LTM Mar 2026 | 22.21M | -5.4% | -3.5% | |
| LTM Feb 2026 | 20.14M | +0.4% | -0.2% | |
| LTM Mar 2026 | 18.61M | +1.3% | +1.4% | |
| LTM Mar 2026 | 16.58M | +0.6% | +0.5% | |
| LTM Mar 2026 | 11.36M | +89.0% | +24.5% | |
| LTM Mar 2026 | 9.94M | +8.7% | +232.8% | |
| Peer median (excluding SLP) | 25.98M | +2.1% | +2.9% | |
Competitors are the stored peer set for SLP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Aug 2021 | FY2022 Aug 2022 | FY2023 Aug 2023 | FY2024 Aug 2024 | FY2025 Aug 2025 |
|---|---|---|---|---|---|
| Revenue | 46.47M | 53.91M | 59.58M | 70.01M | 79.18M |
| Cost of Revenue | 10.6M | 10.82M | 11.63M | 26.86M | 32.96M |
| Gross Profit | 35.87M | 43.08M | 47.95M | 43.15M | 46.22M |
| Gross Margin | 77.2% | 79.9% | 80.5% | 61.6% | 58.4% |
| Research & Development | 4.05M | 3.21M | 4.5M | 5.75M | 6.88M |
| Selling, General & Admin | 20.57M | 24.97M | 34.72M | 31.27M | 32.85M |
| Operating Expenses | 24.61M | 28.17M | 39.22M | 37.02M | 116.95M |
| Depreciation & Amortization | 3.59M | 3.57M | 3.84M | 5.67M | 8.21M |
| EBITDA | 14.7M | 18.69M | 13.07M | 18.08M | 14.7M |
| EBITDA Margin | 31.6% | 34.7% | 21.9% | 25.8% | 18.6% |
| Operating Income | 11.25M | 14.91M | 8.73M | 6.13M | (70.73M) |
| Operating Margin | 24.2% | 27.7% | 14.6% | 8.8% | -89.3% |
| Interest Income | 201K | 717K | 4.13M | 4.38M | 722K |
| Interest Expense | 22K | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (168K) | 204K | 2.97M | 6.28M | 1.35M |
| Income Before Tax | 11.09M | 15.12M | 11.7M | 12.41M | (69.38M) |
| Pre-Tax Margin | 23.9% | 28.0% | 19.6% | 17.7% | -87.6% |
| Income Tax Expense | 1.3M | 2.63M | 1.73M | 2.46M | (4.66M) |
| Net Income | 9.78M | 12.48M | 9.96M | 9.95M | (64.72M) |
| Net Margin | 21.1% | 23.2% | 16.7% | 14.2% | -81.7% |
| EPS (Basic) | 0.49 | 0.62 | 0.50 | 0.50 | (3.22) |
| EPS (Diluted) | 0.47 | 0.60 | 0.49 | 0.49 | (3.22) |
| Weighted Avg Shares | 20.05M | 20.2M | 20.08M | 19.99M | 20.1M |
| Weighted Avg Shares (Diluted) | 20.74M | 20.75M | 20.47M | 20.3M | 20.1M |
Simulations Plus, Inc.
NASDAQ:SLP
Intrinsic Alpha fair value
Locked
Current Price
$18.50
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.